{
  "meta": {
    "title": "Pg_And_Nsaids",
    "url": "https://brainandscalpel.vercel.app/pg-and-nsaids-8b4d8d26.html",
    "scrapedAt": "2025-11-29T18:33:39.133Z"
  },
  "questions": [
    {
      "id": 3899,
      "choices": [
        {
          "id": 15575,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TNF antagonist</span></span></span></p>"
        },
        {
          "id": 15576,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">IL-1 antagonist</span></span></span></p>"
        },
        {
          "id": 15577,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">IL-2 antagonist</span></span></span></p>"
        },
        {
          "id": 15578,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IL-6 antagonist</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A new biological therapy, Anakinra has been developed for treatment of Rheumatoid Arthritis. What is the mechanism of action of anakinra?</span></span></span></p>",
      "unique_key": "Q5083466",
      "question_audio": null,
      "question_video": null,
      "map_id": 35946,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) IL-1 antagonist</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anakinra </strong>is a <strong>biological therapy </strong>used in the <strong>treatment of rheumatoid arthritis </strong>and <strong>other inflammatory conditions</strong>. Its <strong>mechanism of action is as an interleukin-1 </strong>(IL-1) <strong>antagonist</strong>. <strong>Anakinra </strong>works by <strong>competitively inhibiting the binding of IL-1 </strong>to its <strong>receptor</strong>, thereby <strong>blocking the biological activity of IL-1</strong>, a <strong>cytokine </strong>that plays a key role in <strong>causing inflammation </strong>and <strong>tissue damage </strong>in <strong>rheumatoid arthritis</strong>. By <strong>inhibiting IL-1</strong>, <strong>anakinra reduces inflammation</strong>, <strong>decreases joint destruction</strong>, and improves symptoms in patients with rheumatoid arthritis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. TNF antagonist:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is incorrect. <strong>TNF antagonists </strong>are a <strong>class of biologics </strong>that include <strong>drugs such as infliximab</strong>, <strong>etanercept</strong>, and <strong>adalimumab</strong>. They work by inhibiting the action of tumor necrosis factor-alpha (TNF-alpha), not IL-1.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. IL-2 antagonist:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is incorrect. <strong>IL-2 antagonists</strong>, such as <strong>basiliximab and daclizumab</strong>, are used primarily to <strong>prevent rejection </strong>in <strong>organ transplantation </strong>by <strong>inhibiting the action of interleukin-2 </strong>(IL-2), which is different from the mechanism of action of anakinra.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. IL-6 antagonist:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is incorrect. <strong>IL-6 antagonists</strong>, such as <strong>tocilizumab and sarilumab</strong>, are used in the <strong>treatment of rheumatoid arthritis </strong>by <strong>inhibiting the action of interleukin-6 </strong>(IL-6), a different pathway from that targeted by anakinra.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational goal is to <strong>understand the specific mechanism of action of anakinra </strong>in the <strong>treatment of rheumatoid arthritis</strong>. <strong>Recognizing anakinra </strong>as an <strong>IL-1 antagonist </strong>is crucial for understanding its <strong>role in managing inflammation</strong> and <strong>joint damage</strong> in patients with <strong>rheumatoid arthritis, </strong>highlighting the importance of targeted biological therapies in modulating specific pathways involved in the disease process.</span></span></span></p>",
      "correct_choice_id": 15576,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3356,
      "choices": [
        {
          "id": 13403,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patent ductus arteriosus</span></span></span></p>"
        },
        {
          "id": 13404,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature closure of ductus arteriosus</span></span></span></p>"
        },
        {
          "id": 13405,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patent ductus venosus</span></span></span></p>"
        },
        {
          "id": 13406,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature closure of ductus venosus</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 34-week pregnant female with polyhydramnios presents with labour pain. She was treated with indomethacin earlier. Which of the following can be likely outcome in the baby if delivery occurs at this time? </span></span></span></p>",
      "unique_key": "Q4502568",
      "question_audio": null,
      "question_video": null,
      "map_id": 35952,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Premature closure of ductus arteriosus</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Indomethacin</strong>, a <strong>nonsteroidal anti-inflammatory drug </strong>(NSAID), is known to <strong>cause the premature closure of the ductus arteriosus </strong>in the <strong>fetus </strong>when <strong>administered during pregnancy</strong>, particularly in the <strong>third trimester</strong>. The <strong>ductus arteriosus </strong>is a <strong>vital fetal blood vessel </strong>that <strong>connects the pulmonary artery </strong>to the <strong>descending aorta</strong>, <strong>allowing blood to bypass </strong>the <strong>non-functioning fetal lungs</strong>. <strong>Indomethacin inhibits prostaglandin synthesis</strong>, which is necessary for <strong>keeping the ductus arteriosus open</strong>. Therefore, its use in pregnancy, especially close to term, can lead to the premature closure of the ductus arteriosus, potentially resulting in cardiac complications and pulmonary hypertension in the newborn.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Patent ductus arteriosus:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This condition occurs when the <strong>ductus arteriosus fails to close after birth</strong>, leading to <strong>abnormal blood flow </strong>between the <strong>aorta and pulmonary artery</strong>. It is not a direct outcome of indomethacin use during pregnancy; rather, indomethacin is used to encourage the closure of a patent ductus arteriosus in the neonatal period.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Patent ductus venosus:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The <strong>ductus venosus </strong>is a <strong>fetal blood vessel that diverts some blood flow </strong>directly from the <strong>umbilical vein </strong>to the <strong>inferior vena cava</strong>, <strong>bypassing the liver</strong>. A patent ductus venosus after birth is unrelated to indomethacin exposure.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Premature closure of ductus venosus:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Like the <strong>patent ductus venosus</strong>, <strong>premature closure </strong>of this <strong>vessel </strong>is <strong>not </strong>a recognized <strong>outcome of indomethacin </strong>use in <strong>pregnancy</strong>. The ductus venosus naturally closes after birth as part of the normal transition from fetal to neonatal circulation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational objective is to <strong>recognize the potential effects of indomethacin use </strong>during <strong>pregnancy on the fetal cardiovascular system</strong>, specifically the <strong>risk of premature closure </strong>of the <strong>ductus arteriosus</strong>. Understanding the <strong>pharmacological impacts of NSAIDs </strong>on <strong>fetal development </strong>is crucial for <strong>making informed decisions </strong>about <strong>drug use in pregnancy</strong>, highlighting the importance of weighing the benefits against potential risks when managing conditions like polyhydramnios</span></span></span></p>",
      "correct_choice_id": 13404,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3911,
      "choices": [
        {
          "id": 15623,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Furosemide</span></span></span></span></span></span></p>"
        },
        {
          "id": 15624,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Pyrazinamide</span></span></span></span></span></span></p>"
        },
        {
          "id": 15625,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Thiazides</span></span></span></span></span></span></p>"
        },
        {
          "id": 15626,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Sulfinpyrazone</span></span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Gout is precipitated by all except?</span></span></span></span></span></p>",
      "unique_key": "Q1822200",
      "question_audio": null,
      "question_video": null,
      "map_id": 35949,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. D) Sulfinpyrazone</span></span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D:</span></span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Sulfinpyrazone </strong>is a <strong>medication used to treat gout</strong>, as it helps to <strong>reduce high levels of uric acid. </strong>It is a <strong>uricosuric agent </strong>that <strong>increases </strong>the <strong>excretion of uric acid in the urine</strong>, thereby <strong>lowering the uric acid levels </strong>in the <strong>blood </strong>and helping to <strong>prevent gout attacks</strong>. Therefore, it does not precipitate gout but is used to manage it.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A. Furosemide:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">This is a <strong>loop diuretic </strong>that can <strong>lead to increased uric acid levels </strong>in the <strong>blood by competing with uric acid </strong>for excretion in the renal tubules, which can precipitate gout.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Pyrazinamide:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">This <strong>antitubercular medication </strong>can cause <strong>hyperuricemia </strong>by <strong>reducing renal excretion of uric acid</strong>, which can precipitate gout.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. Thiazides:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">These <strong>diuretics </strong>can also <strong>increase uric acid levels </strong>by similar <strong>mechanisms to furosemide</strong>, which can lead to gout flare-ups.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The educational goal is to <strong>recognize the medications</strong> that can <strong>precipitate gout by increasing uric acid levels</strong> and to <strong>differentiate</strong> them from those that are <strong>used to treat gout.</strong></span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Drugs that cause Hyperuricemia</span></span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Alcohol</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Thiazides</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Loop diuretics (Furosemide, Torsemide etc.)</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Salicylates</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Pyrazinamide</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ethambutol</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Nicotinic acid</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Cyclosporine</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytotoxic anticancer drugs</span></span></li>\r\n</ul>",
      "correct_choice_id": 15626,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3877,
      "choices": [
        {
          "id": 15487,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ischemic heart disease </span></span></span></p>"
        },
        {
          "id": 15488,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Epilepsy </span></span></span></p>"
        },
        {
          "id": 15489,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hepatic failure </span></span></span></p>"
        },
        {
          "id": 15490,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">All of the above </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Triptans are a group of drugs used for acute severe migraine. These act by stimulating 5HT1B/1D receptors. In which of the following conditions, triptans should be avoided? </span></span></span></p>",
      "unique_key": "Q4973679",
      "question_audio": null,
      "question_video": null,
      "map_id": 35948,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. D) All of the above</span></span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D:</span></span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Triptans </strong>are <strong>selective serotonin 5-HT1B/1D receptor agonists </strong>and are considered the <strong>treatment of choice for aborting an acute migraine attack</strong>. They include <strong>sumatriptan, almotriptan, frovatriptan, rizatriptan, eletriptan, naratriptan</strong>, and <strong>zolmitriptan</strong>. These medications can cause <strong>coronary vasospasm</strong>, which is a significant risk factor in <strong>ischemic heart disease</strong>. Because of this, and other possible effects on vascular tone and hepatic metabolism, they should be avoided in patients with ischemic heart disease, epilepsy, hepatic failure, and they are also contraindicated in patients with hypertension, renal impairment, and during pregnancy.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A. True</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: &nbsp;<strong>Triptans </strong>can <strong>induce coronary vasospasm</strong>, therefore they are contraindicated in ischemic heart disease. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. True</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: &nbsp;Due to the risk of triggering seizures, <strong>triptans should be avoided in individuals with epilepsy</strong>. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. True</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: <strong>Hepatic failure </strong>can <strong>affect the metabolism of triptans</strong>, leading to <strong>increased levels of the drug </strong>and potential toxicity, hence they should be avoided.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Triptans </strong>are <strong>contraindicated in ischemic heart disease </strong>due to the <strong>risk of coronary vasospasm</strong>, and should also be <strong>avoided in conditions </strong>such as <strong>hypertension, epilepsy, hepatic </strong>or <strong>renal impairment</strong>, and <strong>during pregnancy </strong>due to their <strong>pharmacological effects on vascular tone </strong>and <strong>metabolism</strong>.</span></span></p>",
      "correct_choice_id": 15490,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3355,
      "choices": [
        {
          "id": 13399,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Latanoprost</span></span></span></p>"
        },
        {
          "id": 13400,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alprostadil</span></span></span></p>"
        },
        {
          "id": 13401,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gemeprost</span></span></span></p>"
        },
        {
          "id": 13402,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carboprost</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with bronchial asthma presents with raised intraocular pressure. Treatment of open angle glaucoma in this patient is? </span></span></p>",
      "unique_key": "Q5517686",
      "question_audio": null,
      "question_video": null,
      "map_id": 35951,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Latanoprost </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among the given drugs, only <strong>Latanoprost is a prostaglandin </strong>(PG) derivative used for <strong>open-angle glaucoma</strong>. <strong>Latanoprost </strong>belongs to the <strong>class of prostaglandin F2&alpha; analogs</strong>. It <strong>works by increasing the outflow </strong>of <strong>aqueous humor from the eye</strong>, thereby <strong>reducing intraocular pressure</strong>. This mechanism helps in the <strong>management of open-angle glaucoma</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Alprostadil:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Alprostadil is a <strong>prostaglandin E1 </strong>(PGE1) analog used to <strong>maintain patency of the ductus arteriosus </strong>in certain <strong>congenital heart defects</strong>, not for the treatment of open-angle glaucoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Gemeprost:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Gemeprost is another <strong>prostaglandin E1 </strong>(PGE1) <strong>analog </strong>used for <strong>cervical dilatation in obstetrics </strong>and <strong>gynecology</strong>, not for the treatment of open-angle glaucoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Carboprost</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Carboprost is a <strong>prostaglandin F2&alpha; </strong>(PGF2&alpha;) analog used for <strong>induction of abortion</strong>, not for the treatment of open-angle glaucoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Latanoprost</strong>, a <strong>prostaglandin F2&alpha; analog</strong>, is used for the <strong>treatment of open-angle glaucoma </strong>by <strong>increasing the outflow of aqueous humor </strong>from the <strong>eye</strong>, thereby <strong>reducing intraocular pressure</strong>.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/screenshot-2024-05-08-103814.jpg\" style=\"height:250px; width:1000px\" /></span></span></p>",
      "correct_choice_id": 13399,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3876,
      "choices": [
        {
          "id": 15483,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is an irreversible inhibitor of COX enzyme. </span></span></span></p>"
        },
        {
          "id": 15484,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It reduces in vivo synthesis of prostaglandins. </span></span></span></p>"
        },
        {
          "id": 15485,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Its clearance is independent of plasma concentration. </span></span></span></p>"
        },
        {
          "id": 15486,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It should be avoided in children with viral illness due to risk of development of Reye syndrome. </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following statements about acetyl salicylic acid are true except? </span></span></span></p>",
      "unique_key": "Q6636389",
      "question_audio": null,
      "question_video": null,
      "map_id": 35947,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Its clearance is independent of plasma concentration</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>clearance of acetyl salicylic acid </strong>(aspirin) is <strong>not independent of plasma concentration</strong>. <strong>Aspirin exhibits saturation kinetics </strong>at <strong>high doses</strong>, which means it <strong>changes from first-order kinetics </strong>(where clearance is dependent on drug concentration) to <strong>zero-order kinetics </strong>(where a constant amount of drug is eliminated per unit time regardless of concentration). Therefore, at high doses, the clearance becomes dose-dependent and is not constant.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. True</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Aspirin </strong>is an <strong>irreversible inhibitor of the cyclooxygenase </strong>(COX) <strong>enzyme</strong>, which results in the inhibition of prostaglandin (PG) and thromboxane (TX) synthesis. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. True: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;By <strong>inhibiting the COX enzyme</strong>, <strong>aspirin reduces </strong>the <strong>synthesis of prostaglandins </strong>in the <strong>body</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. True: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Aspirin </strong>should be <strong>avoided in children </strong>with <strong>viral illnesses </strong>because of the associated <strong>risk of Reye&#39;s syndrome</strong>, a serious condition that can cause liver and brain damage.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aspirin </strong>is an <strong>irreversible inhibitor of COX </strong>and <strong>reduces the synthesis of prostaglandins </strong>and <strong>thromboxane</strong>. It shows <strong>saturation kinetics at high doses</strong>, meaning that <strong>clearance becomes constant </strong>and is <strong>not independent of plasma concentration</strong>. Aspirin should be avoided in children with viral illnesses due to the risk of Reye&#39;s syndrome.</span></span></p>",
      "correct_choice_id": 15485,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3913,
      "choices": [
        {
          "id": 15631,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydroxyzine</span></span></span></p>"
        },
        {
          "id": 15632,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diphenhydramine</span></span></span></p>"
        },
        {
          "id": 15633,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cetirizine</span></span></span></p>"
        },
        {
          "id": 15634,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyproheptadine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is an H1-receptor antagonist that also has serotonin receptor antagonistic property on the appetite center. </span></span></p>",
      "unique_key": "Q3827137",
      "question_audio": null,
      "question_video": null,
      "map_id": 35950,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Cyproheptadine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D:</span></span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Cyproheptadine</strong> is an <strong>H1-receptor antagonist </strong>with additional <strong>pharmacological actions</strong>, including <strong>antagonism at serotonin receptors</strong>, particularly <strong>affecting the appetite center</strong>. This makes <strong>cyproheptadine unique</strong> among the <strong>first-generation antihistamines,</strong> as it can be <strong>used off-label as an appetite stimulant</strong> due to its <strong>serotonergic effects.</strong></span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A. Hydroxyzine:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Primarily acts as an H1-receptor antagonist </strong>with <strong>sedative properties </strong>but does not have a notable effect on the appetite center via serotonin antagonism. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Diphenhydramine:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">While it is an <strong>H1-receptor antagonist</strong>, its actions do not prominently include serotonin receptor antagonism related to appetite control. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. Cetirizine:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A <strong>second-generation antihistamine </strong>with a more <strong>specific action on H1 receptors</strong> and less likely to cause sedation or appetite changes.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational goal is to understand the <strong>pharmacological properties of antihistamines,</strong> especially those with additional effects beyond <strong>H1-receptor antagonism</strong>, such as <strong>cyproheptadine</strong>. Recognizing the <strong>dual action of cyproheptadine as both an H1 antagonist</strong> and a <strong>serotonin receptor antagonist </strong>illustrates the <strong>complexity of drug effects </strong>and the importance of selecting the appropriate medication based on the patient&#39;s specific needs.</span></span></p>",
      "correct_choice_id": 15634,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}